20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension

被引:23
作者
Ding, Yan [1 ]
Wu, Cheng-Chia [1 ]
Garcia, Victor [1 ]
Dimitrova, Irina [1 ]
Weidenhammer, Adam [1 ]
Joseph, Gregory [1 ]
Zhang, Frank [1 ]
Manthati, Vijay L. [2 ]
Falck, John R. [2 ]
Capdevila, Jorge H. [3 ]
Schwartzman, Michal L. [1 ]
机构
[1] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
[3] Vanderbilt Univ, Dept Med & Biochem, Nashville, TN 37235 USA
基金
美国国家卫生研究院;
关键词
20-hydroxyeicosatetraenoic acid; cytochrome P-450 4A; blood pressure; androgen; 20-HYDROXYEICOSATETRAENOIC ACID SYNTHESIS; ANGIOTENSIN-II; ENDOTHELIAL DYSFUNCTION; VASCULAR DYSFUNCTION; OXIDATIVE STRESS; ACTIVATION; CONTRIBUTES; INDUCTION; EXCRETION; APOPTOSIS;
D O I
10.1152/ajprenal.00292.2013
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
20-Hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P-450 (Cyp)-derived arachidonic acid metabolite that has been shown to increase smooth muscle contractions and proliferation, stimulate endothelial dysfunction and activation, and promote hypertension. We examined if 20-HETE contributes to microvascular remodeling in hypertension. In Sprague-Dawley rats, administration of the 20-HETE biosynthesis inhibitor HET0016 or the 20-HETE antagonist N-20-hydroxyeicosa-6(Z), 15(Z)-dienoic acid (20-HEDE) prevented 5 alpha-dihydrotestosterone (DHT)-induced increases in blood pressure as well as abrogated DHT-induced increases in the media-to-lumen ratio (M/L), media thickness, and collagen IV deposition in renal interlobar arteries. Reserpine prevented blood pressure elevation in DHT-treated rats but did not affect microvascular remodeling (M/L, media thickness, and collagen deposition); under these conditions, treatment with the 20-HETE antagonist attenuated microvascular remodeling, suggesting that 20-HETE contributes to DHT-induced vascular remodeling independent of blood pressure elevation. In Cyp4a14(-/-) mice, which display androgen-driven and 20-HETE-dependent hypertension, treatment with the 20-HETE antagonist abolished remodeling of renal resistance arteries measured as media thickness (24 +/- 1 vs. 15 +/- 1 mu m) and M/L (0.29 +/- 0.03 vs. 0.17 +/- 0.01). Moreover, in Cyp4a12 transgenic mice in which the expression of Cyp4a12-20-HETE synthase is driven by a tetracycline-sensitive promoter, treatment with doxycycline resulted in blood pressure elevation (140 +/- 4 vs. 92 +/- 5 mmHg) and a significant increase in remodeling of renal resistance arteries (media thickness: 23 +/- 1 vs. 16 +/- 1 mu m; M/L: 0.39 +/- 0.04 vs. 0.23 +/- 0.02); these increases were abrogated by cotreatment with 20-HEDE. This study demonstrated that 20-HETE is a key regulator of microvascular remodeling in hypertension; its effect is independent of blood pressure elevation and androgen levels.
引用
收藏
页码:F753 / F763
页数:11
相关论文
共 43 条
[1]   Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats [J].
Chabova, Vera Certikova ;
Kramer, Herbert J. ;
Vaneckova, Ivana ;
Vernerova, Zdena ;
Eis, Vaclav ;
Tesar, Vladimir ;
Skaroupkova, Petra ;
Thumova, Monika ;
Schejbalova, Stanislava ;
Huskova, Zuzana ;
Vanourkova, Zdenka ;
Kolsky, Alexander ;
Imig, John D. ;
Cervenka, Ludek .
VASCULAR PHARMACOLOGY, 2007, 47 (2-3) :145-159
[2]   20-hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling [J].
Cheng, Jennifer ;
Ou, Jing-Song ;
Singh, Harpreet ;
Falck, John R. ;
Narsimhaswamy, Dubasi ;
Pritchard, Kirkwood A. ;
Schwartzman, Michal Laniado .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (02) :H1018-H1026
[3]   Induction of Angiotensin-Converting Enzyme and Activation of the Renin-Angiotensin System Contribute to 20-Hydroxyeicosatetraenoic Acid-Mediated Endothelial Dysfunction [J].
Cheng, Jennifer ;
Garcia, Victor ;
Ding, Yan ;
Wu, Cheng-Chia ;
Thakar, Krutanjali ;
Falck, John R. ;
Ramu, Errabelli ;
Schwartzman, Michal Laniado .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (08) :1917-U451
[4]   20-Hydroxy-5,8,11,14-eicosatetraenoic Acid Mediates Endothelial Dysfunction via IκB Kinase-Dependent Endothelial Nitric-Oxide Synthase Uncoupling [J].
Cheng, Jennifer ;
Wu, Cheng-Chia ;
Gotlinger, Katherine H. ;
Zhang, Frank ;
Falck, John R. ;
Narsimhaswamy, Dubasi ;
Schwartzman, Michal Laniado .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (01) :57-65
[5]   Angiotensin II releases 20-HETE from rat renal microvessels [J].
Croft, KD ;
McGiff, JC ;
Sanchez-Mendoza, A ;
Carroll, MA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 279 (03) :F544-F551
[6]   Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats [J].
Dunn, Kathryn M. ;
Renic, Marija ;
Flasch, Averia K. ;
Harder, David R. ;
Falck, John ;
Roman, Richard J. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 295 (06) :H2455-H2465
[7]   Media-to-lumen ratio as predictor of renal abnormalities in hypertension: new findings, new questions [J].
Grassi, Guido ;
Schiffrin, Ernesto L. .
JOURNAL OF HYPERTENSION, 2010, 28 (09) :1811-1813
[8]   Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation [J].
Guo, Austin M. ;
Arbab, Ali S. ;
Falck, John R. ;
Chen, Ping ;
Edwards, Paul A. ;
Roman, Richard J. ;
Scicli, A. Guillermo .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01) :18-27
[9]  
Gutkind J S, 2000, Sci STKE, V2000, pre1, DOI 10.1126/stke.2000.40.re1
[10]   Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension [J].
Holla, VR ;
Adas, F ;
Imig, JD ;
Zhao, XY ;
Price, E ;
Olsen, N ;
Kovacs, WJ ;
Magnuson, MA ;
Keeney, DS ;
Breyer, MD ;
Falck, JR ;
Waterman, MR ;
Capdevila, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (09) :5211-5216